Sertraline and akathisia: spontaneous resolution.
Olivera
A O
AO
Department of Psychiatry, MetroHealth Medical Center, Cleveland, Ohio, USA.
D015057:1-Naphthylamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D017109:Akathisia, Drug-Induced / Q000209:etiology*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D012075:Remission, Spontaneous; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D020280:Sertraline
D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline